Implications of emerging risk factors for therapeutic intervention
- 31 October 2005
- journal article
- Published by Elsevier in Nutrition, Metabolism and Cardiovascular Diseases
- Vol. 15 (5) , 373-381
- https://doi.org/10.1016/j.numecd.2005.06.011
Abstract
No abstract availableKeywords
This publication has 40 references indexed in Scilit:
- Implications of Recent Clinical Trials for the National Cholesterol Education Program Adult Treatment Panel III GuidelinesCirculation, 2004
- Intensive versus Moderate Lipid Lowering with Statins after Acute Coronary SyndromesNew England Journal of Medicine, 2004
- European guidelines on cardiovascular disease prevention in clinical practiceThird Joint Task Force of European and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of eight societies and by invited experts)Atherosclerosis, 2004
- Cardiovascular Events in Diabetic and Nondiabetic Adults With or Without History of Myocardial InfarctionCirculation, 2004
- Framingham risk function overestimates risk of coronary heart disease in men and women from Germany—results from the MONICA Augsburg and the PROCAM cohortsEuropean Heart Journal, 2003
- MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20 536 high-risk individuals: a randomised placebocontrolled trialPublished by Elsevier ,2002
- Comparison of cardiovascular risk between patients with type 2 diabetes and those who had had a myocardial infarction: cross sectional and cohort studiesBMJ, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Diabetes and Coronary Heart DiseaseNew England Journal of Medicine, 1998
- Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial InfarctionNew England Journal of Medicine, 1998